451 related articles for article (PubMed ID: 17113254)
21. Nuclear-factor kappa B (NF-kappa B)-inducible nitric oxide synthase (iNOS/NOS II) pathway damages the stria vascularis in cisplatin-treated mice.
Watanabe K; Inai S; Jinnouchi K; Bada S; Hess A; Michel O; Yagi T
Anticancer Res; 2002; 22(6C):4081-5. PubMed ID: 12553036
[TBL] [Abstract][Full Text] [Related]
22. The disruption and hyperpermeability of blood-labyrinth barrier mediates cisplatin-induced ototoxicity.
Gu J; Tong L; Lin X; Chen Y; Wu H; Wang X; Yu D
Toxicol Lett; 2022 Jan; 354():56-64. PubMed ID: 34757176
[TBL] [Abstract][Full Text] [Related]
23. Mechanisms of cisplatin ototoxicity: theoretical review.
Gonçalves MS; Silveira AF; Teixeira AR; Hyppolito MA
J Laryngol Otol; 2013 Jun; 127(6):536-41. PubMed ID: 23651576
[TBL] [Abstract][Full Text] [Related]
24. Dexamethasone loaded nanoparticles exert protective effects against Cisplatin-induced hearing loss by systemic administration.
Sun C; Wang X; Chen D; Lin X; Yu D; Wu H
Neurosci Lett; 2016 Apr; 619():142-8. PubMed ID: 26971701
[TBL] [Abstract][Full Text] [Related]
25. Cisplatin-induced ototoxicity is mediated by nitroxidative modification of cochlear proteins characterized by nitration of Lmo4.
Jamesdaniel S; Coling D; Hinduja S; Ding D; Li J; Cassidy L; Seigel GM; Qu J; Salvi R
J Biol Chem; 2012 May; 287(22):18674-86. PubMed ID: 22493493
[TBL] [Abstract][Full Text] [Related]
26. Ginkgo biloba extract (EGb 761) protects against cisplatin-induced ototoxicity in rats.
Huang X; Whitworth CA; Rybak LP
Otol Neurotol; 2007 Sep; 28(6):828-33. PubMed ID: 17450108
[TBL] [Abstract][Full Text] [Related]
27. Cochlear structure and function after round window application of ototoxins.
Bauer CA; Brozoski TJ
Hear Res; 2005 Mar; 201(1-2):121-31. PubMed ID: 15721567
[TBL] [Abstract][Full Text] [Related]
28. Hydrogen protects auditory hair cells from cisplatin-induced free radicals.
Kikkawa YS; Nakagawa T; Taniguchi M; Ito J
Neurosci Lett; 2014 Sep; 579():125-9. PubMed ID: 25064701
[TBL] [Abstract][Full Text] [Related]
29. Review: ototoxic characteristics of platinum antitumor drugs.
Ding D; Allman BL; Salvi R
Anat Rec (Hoboken); 2012 Nov; 295(11):1851-67. PubMed ID: 23044998
[TBL] [Abstract][Full Text] [Related]
30. Protective effects of apocynin on cisplatin-induced ototoxicity in an auditory cell line and in zebrafish.
Choi J; Im GJ; Chang J; Chae SW; Lee SH; Kwon SY; Chung AY; Park HC; Jung HH
J Appl Toxicol; 2013 Feb; 33(2):125-33. PubMed ID: 22147442
[TBL] [Abstract][Full Text] [Related]
31. Expression of the kidney injury molecule 1 in the rat cochlea and induction by cisplatin.
Mukherjea D; Whitworth CA; Nandish S; Dunaway GA; Rybak LP; Ramkumar V
Neuroscience; 2006 May; 139(2):733-40. PubMed ID: 16464536
[TBL] [Abstract][Full Text] [Related]
32. Light microscopy study of cisplatin-induced ototoxicity in rats.
de Freitas MR; de Castro Brito GA; de Carvalho JV; Gomes RM; Barreto Martins MJ; de Albuquerque Ribeiro R
J Laryngol Otol; 2009 Jun; 123(6):590-7. PubMed ID: 19144244
[TBL] [Abstract][Full Text] [Related]
33. The effectiveness of eugenol against cisplatin-induced ototoxicity.
Sakat MS; Kilic K; Akdemir FNE; Yildirim S; Eser G; Kiziltunc A
Braz J Otorhinolaryngol; 2019; 85(6):766-773. PubMed ID: 30126770
[TBL] [Abstract][Full Text] [Related]
34. Protective effect of Pycnogenol on cisplatin-induced ototoxicity in rats.
Eryilmaz A; Eliyatkin N; Demirci B; Basal Y; Kurt Omurlu I; Gunel C; Aktas S; Toka A; Basak S
Pharm Biol; 2016 Nov; 54(11):2777-2781. PubMed ID: 27158843
[TBL] [Abstract][Full Text] [Related]
35. Short interfering RNA against STAT1 attenuates cisplatin-induced ototoxicity in the rat by suppressing inflammation.
Kaur T; Mukherjea D; Sheehan K; Jajoo S; Rybak LP; Ramkumar V
Cell Death Dis; 2011 Jul; 2(7):e180. PubMed ID: 21776018
[TBL] [Abstract][Full Text] [Related]
36. An Src-protein tyrosine kinase inhibitor to reduce cisplatin ototoxicity while preserving its antitumor effect.
Bielefeld EC; Tanaka C; Chen GD; Coling D; Li M; Henderson D; Fetoni AR
Anticancer Drugs; 2013 Jan; 24(1):43-51. PubMed ID: 22828384
[TBL] [Abstract][Full Text] [Related]
37. Caspase inhibitors, but not c-Jun NH2-terminal kinase inhibitor treatment, prevent cisplatin-induced hearing loss.
Wang J; Ladrech S; Pujol R; Brabet P; Van De Water TR; Puel JL
Cancer Res; 2004 Dec; 64(24):9217-24. PubMed ID: 15604295
[TBL] [Abstract][Full Text] [Related]
38. Protective role of misoprostol against cisplatin-induced ototoxicity.
Doğan M; Polat H; Yaşar M; Kaya A; Bayram A; Şenel F; Özcan İ
Eur Arch Otorhinolaryngol; 2016 Nov; 273(11):3685-3692. PubMed ID: 27052552
[TBL] [Abstract][Full Text] [Related]
39. Rapamycin alleviates cisplatin-induced ototoxicity in vivo.
Fang B; Xiao H
Biochem Biophys Res Commun; 2014 Jun; 448(4):443-7. PubMed ID: 24796670
[TBL] [Abstract][Full Text] [Related]
40. Ginkgolide B protects against cisplatin-induced ototoxicity: enhancement of Akt-Nrf2-HO-1 signaling and reduction of NADPH oxidase.
Ma W; Hu J; Cheng Y; Wang J; Zhang X; Xu M
Cancer Chemother Pharmacol; 2015 May; 75(5):949-59. PubMed ID: 25749575
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
